Evidence map›Paper›PMID 19609614›Full record

ArticleMarine biotechnology (New York, N.Y.)2010

Siphonodictyal B1 from a marine sponge increases intracellular calcium levels comparable to the Ca2+-ATPase (SERCA) inhibitor thapsigargin.

Ulf Bickmeyer, Achim Grube, Karl-Walter Klings, Joseph R Pawlik, Matthias Köck

Abstract read
PubMed Publisher
In one paragraph

Article in Marine biotechnology (New York, N.Y.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ulf BickmeyerAlfred-Wegener-Institut für Polar- und Meeresforschung in der Helmholtz-Gemeinschaft, Biologische Anstalt Helgoland, Kurpromenade 201, 27498 Helgoland, Germany. Ulf.Bickmeyer@awi.de
Achim Grube
Karl-Walter Klings
Joseph R Pawlik
Matthias Köck
Alfred-Wegener-Institut Helmholtz-Zentrum für Polar- und Meeresforschung · DEUniversity of North Carolina Wilmington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Siphonodictyal B1 is a sesquiterpene-hydroquinone isolated from the Caribbean coral reef bioeroding sponge Siphonodictyon coralliphagum. Siphonodictyal B1 increased intracellular calcium levels in neuroendocrine cells (PC12) in the presence and absence of extracellular calcium using Fura-2 as a calcium-sensitive dye. The calcium rise was comparable in amplitude and timing to the application of the sarco-endoplasmic reticulum calcium-ATPase (SERCA) inhibitor thapsigargin from the terrestrial plant Thapsia garganica. The effects of thapsigargin and siphonodictyal B1 on intracellular calcium levels were not distinguishable in pharmacological experiments conducted with caffeine, ryanodine, muscarine, and thapsigargin in calcium-free and calcium-containing buffer, although thapsigargin was effective at lower concentrations. Thapsigargin is a sesquiterpene-lactone and has no structural similarities to siphonodictyal B1. We conclude that thapsigargin and siphonodictyal B1 share SERCAs as cellular targets. Siphonodictyal B1 may be involved in the process of bioeroding the calcium carbonate endoskeleton of the scleractinian corals attacked by S. coralliphagum.

Indexed as

AnimalsCalciumEnzyme InhibitorsHydroquinonesMolecular StructurePC12 CellsPoriferaRatsSarcoplasmic Reticulum Calcium-Transporting ATPasesSesquiterpenesThapsigarginCalciumEnzyme InhibitorsHydroquinonesSarcoplasmic Reticulum Calcium-Transporting ATPasesSesquiterpenessiphonodictyal B1Thapsigargin

Identifiers

PMID19609614
OpenAlexW2156215145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.